U.S., Aug. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07763912) titled 'Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitagliptin/Metformin in Prolonged-release Tablets With 50 mg/1000 mg in Healthy Subjects, Fed Study.' on Aug. 10.
Brief Summary: Prospective, longitudinal, single-dose, randomized, open-label, crossover 2x2, two treatments, two periods, two sequences controlled clinical study
Study Start Date: Nov. 24, 2025
Study Type: INTERVENTIONAL
Condition:
Bioequivalence
Intervention:
DRUG: Reference
Janumet XR, 50 mg/1000 mg, ER tablet, reference
DRUG: Test
Sitagliptin/metformin, ER tablet, 50 mg/1000 mg
Recruitment Status: COMPLETED
Sponsor: ADIUM
Publishe...